This funding, provided through the NIH’s Somatic Cell Genome Editing Program, will support gene-editing research aimed at ...

CAMBRIDGE, Mass. and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: EDIT), a ...

Gene-editing therapies—techniques that modify DNA to treat or prevent disease—have the potential to transform the field of ...

HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company pioneering CRISPR-based programmable genome medicines, today announced the appointment of Dr. TJ Cradick as Chief ...

Researchers in biomedical engineering will use the NIH award to conduct an in-depth analysis of the genetic and cellular determinants of gene therapy longevity.

UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara host the Nobel Prize–winning biochemist for a talk on CRISPR ...

A US startup, Heliospect Genomics, is offering wealthy couples the option to test embryos for IQ amid growing ethical debates ...

In a groundbreaking development, scientists have reconstructed the most complete Tasmanian tiger genome ever assembled, ...

Chief, John Sterling, reviews Tim Harris's latest book, In Pursuit of Unicorns: A Journey through 50 Years of Biotechnology.

CRISPR technology allows for precise DNA modifications, holding promise for treating genetic disorders and revolutionizing ...

Colossal reports significant advancements in thylacine de-extinction efforts, including the generation of the highest quality ...

Successes across the de-extinction pipeline signal that the thylacine project is on track as Colossal continues its global ...